Literature DB >> 23892478

Nitensidine A, a guanidine alkaloid from Pterogyne nitens, induces osteoclastic cell death.

Yasuhiro Tajima1, Hayato Murase, Kazuhiro Satake, Yuji Mitani, Luis Octavio Regasini, Vanderlan da Silva Bolzani, Thomas Efferth, Hiroshi Nakagawa.   

Abstract

Nitensidine A is a guanidine alkaloid isolated from Pterogyne nitens, a common plant in South America. To gain insight into the biological activity of P. nitens-produced compounds, we examined herein their biological effects on osteoclasts, multinucleated giant cells that regulate bone metabolism by resorbing bone. Among four guanidine alkaloids (i.e., galegine, nitensidine A, pterogynidine, and pterogynine), nitensidine A and pterogynine exhibited anti-osteoclastic effects at 10 μM by reducing the number of osteoclasts on the culture plate whereas galegine and pterogynidine did not. The anti-osteoclastic activities of nitensidine A and pterogynine were exerted in a concentration-dependent manner, whereas nitensidine A exhibited an approximate threefold stronger effect than pterogynine (IC50 values: nitensidine A, 0.93 ± 0.024 μM; pterogynine, 2.7 ± 0.40 μM). In the present study, the anti-osteoclastic effects of two synthetic nitensidine A derivatives (nitensidine AT and AU) were also examined to gain insight into the structural features of nitensidine A that exert an anti-osteoclastic effect. The anti-osteoclastic effect of nitensidine A was greatly reduced by substituting the imino nitrogen atom in nitensidine A with sulfur or oxygen. According to the differences in chemical structures and anti-osteoclastic effects of the four guanidine alkaloids and the two synthetic nitensidine A derivatives, it is suggested that the number, binding site, and polymerization degree of isoprenyl moiety in the guanidine alkaloids and the imino nitrogen atom cooperatively contribute to their anti-osteoclastic effects.

Entities:  

Year:  2013        PMID: 23892478      PMCID: PMC4474991          DOI: 10.1007/s10616-013-9590-2

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  27 in total

Review 1.  Therapeutic approaches to bone diseases.

Authors:  G A Rodan; T J Martin
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

2.  Potent inhibitory effect of naturally occurring flavonoids quercetin and kaempferol on in vitro osteoclastic bone resorption.

Authors:  Alice Wattel; Said Kamel; Romuald Mentaverri; Florence Lorget; Christophe Prouillet; Jean-Pierre Petit; Patrice Fardelonne; Michel Brazier
Journal:  Biochem Pharmacol       Date:  2003-01-01       Impact factor: 5.858

Review 3.  Osteoclast differentiation and activation.

Authors:  William J Boyle; W Scott Simonet; David L Lacey
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

4.  Identification and characterization of the precursors committed to osteoclasts induced by TNF-related activation-induced cytokine/receptor activator of NF-kappa B ligand.

Authors:  Ayako Mochizuki; Masamichi Takami; Tadaharu Kawawa; Reina Suzumoto; Takahisa Sasaki; Akihiko Shiba; Hiroaki Tsukasaki; Baohong Zhao; Rika Yasuhara; Tetsuo Suzawa; Yoichi Miyamoto; Yongwon Choi; Ryutaro Kamijo
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

5.  Identification of two biologically crucial hydroxyl groups of (-)-epigallocatechin gallate in osteoclast culture.

Authors:  Hiroshi Nakagawa; Keiji Hasumi; Masamichi Takami; Sachiko Aida-Hyugaji; Je-Tae Woo; Kazuo Nagai; Toshihisa Ishikawa; Masaaki Wachi
Journal:  Biochem Pharmacol       Date:  2006-09-12       Impact factor: 5.858

6.  Alkaloids extracted from Pterogyne nitens induce apoptosis in malignant breast cell line.

Authors:  Roberta Aparecida Duarte; Elaine Rodrigues Mello; Camila Araki; Vanderlan da Silva Bolzani; Dulce Helena Siqueira e Silva; Luis Octavio Regasini; Tarsia Giabardo Alves Silva; Mauro César Cafundó de Morais; Valdecir Farias Ximenes; Christiane Pienna Soares
Journal:  Tumour Biol       Date:  2010-08-11

Review 7.  Bone resorption by osteoclasts.

Authors:  S L Teitelbaum
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

8.  Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis.

Authors:  Baohong Zhao; Masamichi Takami; Atsushi Yamada; Xiaogu Wang; Takako Koga; Xiaoyu Hu; Tomohiko Tamura; Keiko Ozato; Yongwon Choi; Lionel B Ivashkiv; Hiroshi Takayanagi; Ryutaro Kamijo
Journal:  Nat Med       Date:  2009-08-30       Impact factor: 53.440

9.  Destruxins, cyclodepsipeptides, block the formation of actin rings and prominent clear zones and ruffled borders in osteoclasts.

Authors:  H Nakagawa; M Takami; N Udagawa; Y Sawae; K Suda; T Sasaki; N Takahashi; M Wachi; K Nagai; J T Woo
Journal:  Bone       Date:  2003-09       Impact factor: 4.398

10.  Evaluation of pharmaceuticals with a novel 50-hour animal model of bone loss.

Authors:  Yoshiya Tomimori; Kaoru Mori; Masanori Koide; Yuko Nakamichi; Tadashi Ninomiya; Nobuyuki Udagawa; Hisataka Yasuda
Journal:  J Bone Miner Res       Date:  2009-07       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.